|
|
 |
FRIDAY, JUNE 23, 2006
7:00 am
Registration Opens
8:30 am - 12:30 pm
Hypertension Academy CME: 4/CEU: .4
What the Practitioner Needs to Know to Effectively Measure and Treat Hypertension
Elijah Saunders, MD
Modifying the Office Environment to Improve Blood Pressure Measurement and Management
Samar Nasser, PA-C, MPH
Overview of Antihypertensive Drugs
Domenic Sica, MD
Novel Approaches to Lowering Blood Pressure in Tough to Control Patients
Angela Brown, MD
Opportunities and Pitfalls in Treating Hypertension in Persons with Chronic Kidney Disease
Matthew Weir, MD
Debate: Diuretics Have Been Overemphasized as Antihypertensive Agents
Kenneth Jamerson, MD - PRO
Jackson Wright, MD - CON
Supported by an educational grant from Abbott Laboratories
2:00 pm - 4:00 pm
Opening Ceremony/Neil Shulman Lecture: ISHIB Partners' Summit --
The Evolution of Hypertension and Cardiovascular Risk: A 20-Year Perspective CME: 2/CEU: .2
Jointly Sponsored by ISHIB; Centers for Disease Control and Prevention (CDC); the National Heart, Lung, and Blood Institute (NHLBI); and the Jackson Heart Study.
The Jackson Heart Study
Herman Taylor, Jr., MD, MPH
The State of Cardiovascular Health Worldwide
George A. Mensah, MD
The Future of Cardiovascular Health: An NHLBI Prospective
Peter Savage, MD
Hypertension: A 20-Year ISHIB Perspective
Elijah Sanders, MD
Supported by an educational grant from AstraZeneca
5:00 pm
Registration Closes
5:30 pm - 6:30 pm
ISHIB 20th Anniversary Celebration
Founders’ Recognition Reception
Supported by AstraZeneca
6:30 pm - 8:30 pm
ISHIB 20th Anniversary Celebration
Founders’ Recognition Banquet
*Attire: Black-tie
Supported by AstraZeneca
SATURDAY, JUNE 24, 2006
7:00 am
Registration Opens
8:00 am - 11:00 am, 3:00 pm - 6:30 pm
Exhibition Open
8:00 am - 10:00 am
Lifestyle Modification Workshop - Culturally Relevant Lifestyle Interventions to Decrease the Metabolic Syndrome CME: 2/CEU: .2
Stress and African American Women: Implications for Clinical Practice
Mary Webb, PhD, RN
Modifying the DASH Diet for Soul Food
Jenice Rankins, EdD
Where Are the Tools? Web Resources to Support Lifestyle Changes
Temple Robinson, MD
10:00 am - 11:00 am
Continuing Education Committee Meeting
Ethnicity & Disease Editorial Board Meeting
11:00 am - 1:00 pm
ISHIB2006 Round Table Lunch Symposium - Answering the Challenges of Cardiovascular Disease and Metabolic Risk: What Should Every Practitioner Know? CME: 2/CEU: .2
The Metabolic Environment in Race and Ethnicity
Sherita Hill Golden, MD, MPH
CVD and the Metabolic Environment - The Need for an Evidence Based Plan
Keith C. Ferdinand, MD
The Link Between CVD and the Metabolic Environment - Emerging Evidence
Brent M. Egan, MD
Supported by an educational grant from Merck & Co., Inc.
1:00 pm – 3:00 pm
Plenary Session I - Diabetes and Its Risk Factors as a True Outcome of the Metabolic Syndrome CME: 2/CEU: .2
Metabolic Syndrome: A Prelude to Diabetes and Its Long-Term Complications?
Sandeep Gupta, MD
Ethnic Differences in Diabetes and the Metabolic Syndrome
Kwame Osei, MD
Diabetes and Cardiovascular Disease: Reducing Risk and End Organ Damage
Rita J. Louard, MD
3:30 pm - 5:00 pm
Workshop A – Metabolic Syndrome in Children
and Adolescents CME: 1.5/CEU: .15
Overview on Epidemiology, Prevalence and Implications for Premature Cardiovascular Disease
Elizabeth Rappaport, MD
Metabolic Syndrome in African American Children and Adolescents
Silva Arslanian, MD
Metabolic Syndrome in Hispanic Children and Adolescents
Martha Cruz, DVM, DPhil
3:30 pm - 4:30 pm
Workshop B – Obesity: Risk Factors and Management CME: 1/CEU: .1
Medications for Obesity Management: Prescription and Over-the-Counter Options
David Kountz, MD
Surgical Procedures for the Treatment of Obesity
Dennis C. Smith, Jr., MD
5:00 pm
Registration Closes
5:00 pm - 6:30 pm
Exhibit Reception/Abstract Poster Session
Supported by an educational grant from Novartis Pharmaceuticals
6:00 pm – 9:00 pm
Dinner Symposium - Screen and Intervene - - A Year 2006 Hypertension and Cardiovascular Disease Update CME: 2/CEU: .2
Blood Pressure: In Control or Out of Control? An Epidemiological Examination of How Well We Are Managing Hypertension in Ethnic Minority Populations and the Importance of Early Risk Identification and Intervention-Getting to Goal and Staying There
Karol E. Watson, MD, PhD
Hypertension: A Systemic Disease Requiring Systematic Approaches to Therapy-Recent Clinical Practice Recommendations Focusing on Combination Therapy in Difficult-to-Treat Patient Populations with High Blood Pressure and Compelling Conditions
Keith C. Ferdinand, MD
The Foundation Role of Calcium Channel Blockers and ACE Inhibitors for Hypertension Management in Ethnic Minority Populations-Evidence, Clinical Trials, and the Prediction of Outcomes: When Combination Therapy Makes Sense
Elijah Saunders, MD
Presenting: Real World Strategies for Optimizing Management of High Blood Pressure, Cardiac Risk Factors, and Preventing End Organ Disease
Domenic A. Sica, MD
Supported by an educational grant from Novartis Pharmaceuticals
SUNDAY, JUNE 25, 2006
6:00 am
Registration Opens
6:30 am - 8:00 am
Breakfast Symposium - Atherothrombosis Management in High-Risk Populations: Clinical Development and Practice Implications CME: 1.5/CEU: .15
Atherothrombosis Management in High-Risk Populations: Clinical Development and Practice Implications
Prevention and Management of Stroke in High-Risk Populations
Bruce Ovbiagele, MD
Cardiovascular Risk Assessment and Management in High-Risk Patients with Peripheral Arterial Disease
Donna Mendes, MD
Supported by an educational grant from Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership
8:00 am - 11:00 am, 3:00 pm - 6:30 pm
Exhibition Open
8:30 am - 10:30 am
Plenary Session II - Hypertension to Heart Failure: A Cardiovascular Disease Continuum CME: 2/CEU: .2
A-Heft and BiDil for Heart Failure in Blacks
Anne Taylor, MD
Energy Metabolism and Hypertension
Lizzy Brewster, MD
Inflammation, Coronary Heart Disease and Race
Michelle Albert, MD, MPH
11:00 am - 1:00 pm
Lunch Symposium - Treatment Options for the Patient With Multiple Comorbidities CME: 2/CEU: .2
Strategies for the Prevention of Macrovascular and Microvascular Complications in the Patient With Diabetes and Hypertension
John M. Flack, MD, MPH
The Cardiovascular Disease Continuum: Therapeutic Options and Class Effects
Domenic A. Sica, MD
Renin-Angiotensin Blockade and Diabetes: Where to Go Next?
Shawna D. Nesbitt, MD, MS
Supported by an educational grant from GlaxoSmithKline
1:00 pm - 3:00 pm
Special Session - Hypertension, Complications, and Chronic Diseases in the Post-Katrina Environment: Development of an Action Plan to Address the Health Issues CME: 2.0/CEU: .2
What Really Happened? The Human Face of Katrina
Keith C. Ferdinand, MD
Pre-Katrina Storms: The Underlying Epidemiology of Chronic Diseases
Evangeline Franklin, MD
Post-Katrina Storms: The Burden of Disease Leading to Poor Health and Compounding the Effects of a Disaster
Cheryl Taylor, PhD, RN
The Plan and Call to Action: Steps to Curb the Increase of Chronic Disease in the Aftermath of Katrina
Kevin U. Stephens, Sr., MD, JD
3:30 pm - 5:00 pm
Workshop C – Metabolic Syndrome and Its Role In Chronic Kidney Disease CME: 1.5/CEU: .15
Antihypertensives and Their Effect on Insulin Resistance
Susanne Nicholas, MD, PhD
Metabolic Syndrome Predicts Risk of Chronic Kidney Disease
Paul Whelton, MD
Obesity, Metabolic Syndrome, and Family History of End Stage Renal Disease
William McClellan, MD
3:30 pm - 4:30 pm
Workshop D – Metabolic Syndrome and the Stroke Continuum CME: 1/CEU: .1
Stroke Risk Factors and Their Evaluation
Galen Henderson, MD
Current Paradigms for the Treatment of Stroke
Salina Waddy, MD
5:00 pm
Registration Closes
5:00 pm - 6:30 pm
Exhibit Reception/Abstract Poster Session
Supported by an educational grant from Novartis Pharmaceuticals
6:30 pm – Midnight
Exhibit Breakdown
6:00 pm - 9:00 pm
Dinner Symposium - Insights into Managing an Epidemic: Hypertensive Black Patients at Risk for Cardiovascular Disease CME:2/CEU: .2
The Epidemic of the Metabolic Syndrome and Cardiovascular Complications in Blacks
George A. Mensah, MD
Pharmacologic Considerations in the Difficult-to-Treat Black Hypertensive Patient
Domenic A. Sica, MD
Management of Hypertension in Black Patients: Making the Right Choices
William Cushman, MD
"Real-World" Patient Management: Panel Discussion
Luther T. Clark, MD
Supported by an educational grant from the Bristol-Myers Squibb Sanofi-Synthelabo Partnership
MONDAY, JUNE 26, 2006
7:00 am
Registration Opens
8:30 am - 10:30 am
Plenary Session III - Lipid Abnormalities with Metabolic Syndrome and Cardiovascular Disease CME: 2/CEU: .2
Ethnic Differences in Triglyceride Levels Contribute to the Under-Diagnosis of the Metabolic Syndrome in African Americans
Anne Sumner, MD
Emerging Therapies in the Management of the Metabolic Syndrome
Elizabeth Ofili, MD, MPH
Management of Metabolic Syndrome: Importance of Therapeutic Lifestyle Modification
Shiriki Kumanyika, PhD, MPH
10:00 am
Registration Closes
11:00 am - 12:00 pm
ISHIB Annual Members Meeting
12:00 pm – 1:30 pm
Hypertension Guidelines Working Group Meeting
^back to top
|
|
